EcoDrugPlus

Ensembl ID : ENSUAMG00000026148
Gene Symbol: -
Cross references: -
130 Possible Orthologues:

Ensembl ID : ENSUAMG00000025162
Gene Symbol: -
Cross references: -
176 Possible Orthologues:

Ensembl ID : ENSUAMG00000027873
Gene Symbol: -
Cross references: -
157 Possible Orthologues:

Ensembl ID : ENSUAMG00000027875
Gene Symbol: -
Cross references: -
157 Possible Orthologues:

Ensembl ID : ENSUAMG00000025061
Gene Symbol: -
Cross references: -
285 Possible Orthologues:

Ensembl ID : ENSUAMG00000023679
Gene Symbol: -
Cross references: -
213 Possible Orthologues:

Ensembl ID : ENSUAMG00000023676
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSUAMG00000023646
Gene Symbol: -
Cross references: -
127 Possible Orthologues:

Ensembl ID : ENSUAMG00000028130
Gene Symbol: -
Cross references: -
86 Possible Orthologues:

Ensembl ID : ENSUAMG00000022546
Gene Symbol: -
Cross references: -
152 Possible Orthologues:

Ensembl ID : ENSUAMG00000022545
Gene Symbol: -
Cross references: -
152 Possible Orthologues:

Ensembl ID : ENSUAMG00000022533
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).